CN(C)CCCNc1nc2cc(-c3ccc4c(ccn4C)c3)sc2c(=O)n1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?